AJU IB Investment Co., Ltd. Long-Term Concentrated

CIK: 0001710065 · Show all filings

Period: Q4 2025 (← Previous)

Filing Date: Feb 10, 2026

Total Value ($000): $22,788 (100.0% shares, 0.0% debt)

Holdings (7)

Decreased Positions (3)

ACLX ARCELLX INC 63.9%

Value ($000) $14,571 (-83.1%) Shares 223,486 (-78.7%) Est. Cost $16.72 Unrealized +377.1%

KYMR KYMERA THERAPEUTICS INC 6.7%

Value ($000) $1,529 (-94.1%) Shares 19,648 (-95.7%) Est. Cost $48.78 Unrealized +38.4%

— SUTRO BIOPHARMA INC 0.9%

Value ($000) $202 (+32.2%) Shares 17,500 (-90.0%) Est. Cost $21.71 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ACLX	ARCELLX INC	223,486 (-78.7%)	$14,571 (-83.1%)	63.9%	$16.72	+377.1%	COMMON STOCK	03940C100
KYMR	KYMERA THERAPEUTICS INC	19,648 (-95.7%)	$1,529 (-94.1%)	6.7%	$48.78	+38.4%	COM	501575104
—	SUTRO BIOPHARMA INC	17,500 (-90.0%)	$202 (+32.2%)	0.9%	$21.71	—	COM	869367102

Unchanged Positions (4)

— RALLYBIO CORP 18.2%

Value ($000) $4,142 Shares 754,678 Est. Cost $9.54 Unrealized —

SEER SEER INC 6.6%

Value ($000) $1,494 Shares 816,375 Est. Cost $63.62 Unrealized -96.8%

XLO XILIO THERAPEUTICS INC 1.9%

Value ($000) $427 Shares 667,742 Est. Cost $17.03 Unrealized -95.6%

— RAPT THERAPEUTICS INC 1.8%

Value ($000) $421 Shares 12,437 Est. Cost $19.75 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	RALLYBIO CORP	754,678	$4,142	18.2%	$9.54	—	COM	75120L100
SEER	SEER INC	816,375	$1,494	6.6%	$63.62	-96.8%	COM CL A	81578P106
XLO	XILIO THERAPEUTICS INC	667,742	$427	1.9%	$17.03	-95.6%	COM	98422T100
—	RAPT THERAPEUTICS INC	12,437	$421	1.8%	$19.75	—	COM NEW	75382E109